Thursday Sep 11
C.R. Bard COO Sells $4,063,261 in Stock
C.R. Bard COO John H. Weiland sold 27,179 shares of the stock in a transaction that occurred on Wednesday, September 10th. The shares were sold at an average price of $149.50, for a total transaction of $4,063,260.50.
Thursday Sep 11
Paulson, Mindich and Soros Bought Covidien; Should You?
In this article, let's take a look at Covidien PLC . , a $41.12 billion market cap company, that develops, makes and distributes medical devices and supplies and other health care products.
Tue Sep 09, 2014
Boston Scientific ordered to pay $73 million over mesh device
A Texas jury has ordered Boston Scientific Corp to pay $73 million to a woman who said she suffered serious injuries from a transvaginal mesh device, the first loss for the device maker in one of thousands of suits over the products. The damage award and finding of gross negligence against the company came Monday evening following a two-week trial in a state court in Dallas, Texas, according to court filings.
LED Medical Diagnostics Announces Jody Kelly as Vice President of Finance
"We are excited that Jody has accepted the role as VP of Finance with , CEO. "In addition to her financial and accounting background, Jody has a depth of expertise in process design/compliance and internal control design - skills we will be able to leverage during the high rate of growth we anticipate as we continue to evolve from a single product manufacturer to a comprehensive North American supplier of dental digital imaging technologies."
Global PTCA balloon catheter market: 8.2% CAGR growth forecast between 2012-81
One of the key factors contributing to this market growth is the increasing prevalence of CVD. The Global PTCA Balloon Catheter market has also been witnessing an increase in demand for minimally invasive procedures.
Mon Sep 08, 2014
C.R. Bard Receives "A+" Credit Rating
C.R. Bard has received an "A+" credit rating from analysts at Morningstar . The agency's "A+" rating suggests that the company is a low default risk.
Sun Sep 07, 2014
No More a Simple Distributor
In this article, let's take a look at CR Bard Inc. , a $11.21 billion market cap company, which is a diversified maker of therapeutic and diagnostic medical devices has exposure to the vascular, urology, oncology, and specialty surgical markets. The company was a distributor of urological devices, but now turned into a diversified medical device firm.
Fri Sep 05, 2014
Second Federal Ethicon Transvaginal Mesh Lawsuit Trial a $3.25...
According to Reuters, the jury hearing the case in the U.S. District Court, Southern District of to a woman who was implanted with the Gynecare TVT Obturator, or TVT-O, pelvic mesh device. Following two weeks of testimony, Johnson & Johnson's Ethicon, Inc. unit was found liable for selling a defective product, and for failing to warn patients and doctors about the risks associated with the device.
Jury hits Ethicon with $3.25 million verdict in me...
A federal jury in West Virginia on Friday awarded a woman $3.27 million in one of 33,000 lawsuits that accuse Johnson & Johnson's Ethicon Inc unit of selling defective transvaginal mesh devices. Following a nearly two-week trial, jurors found Ethicon liable for selling faulty devices and failing to warn patients and their doctors that users were at risk from side effects that include pain, bleeding and infection.
Thu Sep 04, 2014
C.R. Bard CEO Timothy M. Ring Sells 10,228 Shares
C.R. Bard CEO Timothy M. Ring unloaded 10,228 shares of C.R. Bard stock on the open market in a transaction that occurred on Tuesday, September 2nd. The stock was sold at an average price of $148.83, for a total transaction of $1,522,233.24.
Wed Aug 20, 2014
The High-Yield Vs. Low-Yield Battle
In two previous articles I reviewed how the highest- and lowest-yielding Dividend Champions got to where they are today.
Medical Device Stocks Report
Deerfield Beach, FL / Aug 20, 2014 / 2013 was a challenging year for the medical device industry.
Mon Aug 18, 2014
The Characteristics Of The Highest-Yielding Dividend Champions
In a recent article I summarized the lowest-yielding Dividend Champions - companies that have not only paid but also increased dividends for a minimum of 25 consecutive years.
Deals of the day- Mergers and acquisitions
** Sensors and electrical controls maker Sensata Technologies Holding NV said it would buy Schrader International for an enterprise value of $1 billion to meet growing demand for sensors to monitor car-tire pressure.
ConvaTec owners eye 2015 sale as buyout interest builds-sources
ConvaTec's private equity owners plan to explore a sale of the medical device maker next year, even as interest from several healthcare companies in a potential $10 billion acquisition intensifies, according to people familiar with the matter.